ARCHIVES

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews

This article is from The Cancer Letter archive.

Vol. 29 No. 05 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Subcommittee Vote: $950 Million Plus training DeVita Needs New Clinical Assistant

July 21, 1978

NCI Resumes Clinical Education Grants

March 18, 1983

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

Mass. Congressman Pressed For $1.5 M Proton Beam Funds

August 18, 1989

Cell Behavior Changes Noted At Baltimore Symposium

January 8, 1982